RBC makes Whistle Stop Tour at AACC

RBC Capital Markets analyst viewed the latest offerings from Abbott/Celera, Beckman Coulter, Dade Behring, Gen-Probe, Immucor and Roche as part of the second annual RBC Whistle Stop Tour during the AACC annual meeting,.

Offerings for the small- to mid-volume testing market seemed to be a recurring theme among tour participants, according to the analyst.

Highlights from the tour included top pick Abbott's real-time PCR instrument, developed in conjunction with Celera, outperform-rated Immucor's mid-volume typing and screening instrument, the Echo and two products from sector perform-rated Dade Behring, StreamLAB and the Vista.

Outperforming Beckman Coulter featured its DxC 600i instrument for the mid-volume lab while Roche displayed its cobas 6000 integrated (chemistry and immunochemistry) analyzer.

The analyst also viewed outperform-rated Gen-Probe's Tigris instrument.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.